Browse the detailed record of transactions filed by Huang James, Director. Director active across 3 companies, notably Ziopharm Oncology INC. Aggregated, 9 disclosures have been logged. Total volume traded: €452k. The latest transaction was disclosed on 22 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
James Huang is a Director at ZIOPHARM Oncology Inc, Windtree Therapeutics Inc, and Alaunos Therapeutics, Inc. In this role, he participates in the governance of the companies and in strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions.